2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424.
4. Chen PC, Muo CH, Lee YT, Yu YH, Sung FC. Lung cancer and incidence of stroke: a population-based cohort study. Stroke 2011;42:3034–3039.
5. Chung JW, Cho YH, Ahn MJ, Lee MJ, Kim GM, Chung CS, et al. Association of cancer cell type and extracellular vesicles with coagulopathy in patients with lung cancer and stroke. Stroke 2018;49:1282–1285.
7. Emre U, Gunes T, Pinar I, Kokturk F, Liman E, Yağiz O. Evaluation of ischemic stroke patients with systemic cancer. Ideggyogy Sz 2018;71:178–183.
8. Feigin V, Norrving B, Sudlow CLM, Sacco RL. Updated Criteria for Population-Based Stroke and Transient Ischemic Attack Incidence Studies for the 21st Century. Stroke 2018;49:2248–2255.
10. Grazioli S, Paciaroni M, Agnelli G, Acciarresi M, Alberti A, D'Amore C, et al. Cancer-associated ischemic stroke: A retrospective multicentre cohort study. Thromb Res 2018;165:33–37.
11. Guo YJ, Chang MH, Chen PL, Lee YS, Chang YC, Liao YC. Predictive value of plasma (D)-dimer levels for cancer-related stroke: a 3-year retrospective study. J Stroke Cerebrovasc Dis 2014;23:249–254.
12. Hanibuchi M, Kim SJ, Fidler IJ, Nishioka Y. The molecular biology of lung cancer brain metastasis: an overview of current comprehensions and future perspectives. J Med Invest 2014;61:241–253.
13. Karlińska AG, Gromadzka G, Karliński MA, Członkowska A. The activity of malignancy may determine stroke pattern in cancer patients. J Stroke Cerebrovasc Dis 2015;24:778–783.
16. Lee EJ, Nah HW, Kwon JY, Kang DW, Kwon SU, Kim JS. Ischemic stroke in patients with cancer: is it different from usual strokes? Int J Stroke 2014;9:406–412.
17. Liu Y, Cao X. Characteristics and Significance of the Pre-metastatic Niche. Cancer Cell 2016;30:668–681.
18. Mohan Rajwani K, Crocker M, Moynihan B. Decompressive craniectomy for the treatment of malignant middle cerebral artery infarction. Br J Neurosurg 2017;31:401–409.
21. Qureshi AI, Malik AA, Saeed O, Adil MM, Rodriguez GJ, Suri MF. Incident cancer in a cohort of 3,247 cancer diagnosis free ischemic stroke patients. Cerebrovasc Dis 2015;39:262–268.
25. Selvik HA, Thomassen L, Logallo N, Næss H. Prior cancer in patients with ischemic stroke: the Bergen NORSTROKE study. J Stroke Cerebrovasc Dis 2014;23:919–925.
27. Sun YP, Wang X, Gao YS, Zhao S, Bai Y. Primary cardiac sarcoma complicated with cerebral infarction and brain metastasis: A case report and literature review. Cancer Biomark 2017;21:247–250.
28. Taillibert S, Le Rhun É. Epidemiology of brain metastases. Cancer Radiother 2015;19:3–9.
30. Wang JY, Zhang GJ, Zhuo SX, Wang K, Hu XP, Zhang H, et al. D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients. Neurol Res 2018;40:948–954.